Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Olmesartan
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/03/2020
Narciclasine
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/02/2020
Homoharringtonine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020
Anisomycin
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/02/2020
Leporin A
Potential treatment - theoretical effect Natural product Antiviral Dec/02/2020
Simeprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020
Oleanolic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/02/2020
7,4-di-O-galloyltricetifavan
Potential treatment - theoretical effect Natural product Antiviral Dec/02/2020
Rilpivirine
Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/02/2020
3,3-Dimethyl-N-[4-(piperidin-1-ylcarbonyl)phenyl]butanamide
Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020
Gnetin-D
Potential treatment - theoretical effect Natural product Antiviral Dec/01/2020
IPAVFK
Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020
ALMPHIR
Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020
ACE2 microbody
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/01/2020
Dalbavancin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/01/2020
YF-S0
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/01/2020
Neohesperidin
Potential treatment - theoretical effect Natural product Antiviral Nov/30/2020
Docetaxel
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/30/2020
Bicalutamide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/30/2020
GSK-256066
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/30/2020